FATE THERAPEUTICS INC (FATE) Free cash flow 2016–2025
FATE THERAPEUTICS INC (FATE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$112.0MFY2025 · since FY2016: -$30.3M → -$112.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$112.0M | +9.4% |
| FY2024 | -$123.6M | +10.7% |
| FY2023 | -$138.4M | +51.2% |
| FY2022 | -$283.8M | -32.9% |
| FY2021 | -$213.6M | -383.6% |
| FY2020 | -$44.2M | +51.2% |
| FY2019 | -$90.6M | -121.2% |
| FY2018 | -$41.0M | -6.3% |
| FY2017 | -$38.5M | -27.3% |
| FY2016 | -$30.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More FATE financial trends
FATE RevenueFATE Net incomeFATE Net marginFATE Gross profitFATE Gross marginFATE Operating incomeFATE Operating marginFATE Operating cash flowFATE Capital expendituresFATE Return on equityFATE Stock buybacksFATE Dividends paidFATE Total assetsFATE Total liabilitiesFATE Shareholders’ equityFATE overview →